▶ 調査レポート

多発性硬化症向け幹細胞療法の世界市場:市場規模・現状・予測

• 英文タイトル:Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。多発性硬化症向け幹細胞療法の世界市場:市場規模・現状・予測 / Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2019-2025 / QYR9ST04259資料のイメージです。• レポートコード:QYR9ST04259
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、多発性硬化症向け幹細胞療法の世界市場について調査・分析し、多発性硬化症向け幹細胞療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(静脈内、脳室内)、用途別(再発寛解型多発性硬化症(RRMS)、原発性進行性多発性硬化症(PPMS)、続発性進行性多発性硬化症(SPMS)、進行性再発性多発性硬化症(PRMS))、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の多発性硬化症向け幹細胞療法市場動向
・主要企業別マーケットシェア
・多発性硬化症向け幹細胞療法の種類別市場規模2014-2019
(静脈内、脳室内)
・多発性硬化症向け幹細胞療法の用途別市場規模2014-2019
(再発寛解型多発性硬化症(RRMS)、原発性進行性多発性硬化症(PPMS)、続発性進行性多発性硬化症(SPMS)、進行性再発性多発性硬化症(PRMS))
・多発性硬化症向け幹細胞療法の北米市場:主要企業・種類別/用途別市場規模
・多発性硬化症向け幹細胞療法のヨーロッパ市場:主要企業・種類別/用途別市場規模
・多発性硬化症向け幹細胞療法の中国市場:主要企業・種類別/用途別市場規模
・多発性硬化症向け幹細胞療法の日本国内市場:主要企業・種類別/用途別市場規模
・多発性硬化症向け幹細胞療法の東南アジア市場:主要企業・種類別/用途別市場規模
・多発性硬化症向け幹細胞療法のインド市場:主要企業・種類別/用途別市場規模
・多発性硬化症向け幹細胞療法の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(American CryoStem、Athersys、Celgene Cellular Therapeutics、Cell Cure Neurosciences)
・多発性硬化症向け幹細胞療法の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision, and tingling.The introduction of mesenchymal stem cells therapy is one of the most promising investigational approach to treat multiple sclerosis, the global multiple sclerosis market will witness growth in the forthcoming years. it has been observed that the American cryostem and celgene cellular therapeutics have their stem cell therapy candidates for the treatment of multiple sclerosis in phase I stage of development.
In 2018, the global Stem Cell Therapy for Multiple Sclerosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Stem Cell Therapy for Multiple Sclerosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell Therapy for Multiple Sclerosis development in United States, Europe and China.

The key players covered in this study
American CryoStem
Athersys
Celgene Cellular Therapeutics
Cell Cure Neurosciences

Market segment by Type, the product can be split into
Intravenous
Intracerebroventricular

Market segment by Application, split into
Relapsing-Remitting Multiple Sclerosis (RRMS)
Primary Progressive Multiple Sclerosis (PPMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Progressive Relapsing Multiple Sclerosis (PRMS)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Stem Cell Therapy for Multiple Sclerosis status, future forecast, growth opportunity, key market and key players.
To present the Stem Cell Therapy for Multiple Sclerosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Stem Cell Therapy for Multiple Sclerosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Intravenous
1.4.3 Intracerebroventricular
1.5 Market by Application
1.5.1 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2014-2025)
1.5.2 Relapsing-Remitting Multiple Sclerosis (RRMS)
1.5.3 Primary Progressive Multiple Sclerosis (PPMS)
1.5.4 Secondary Progressive Multiple Sclerosis (SPMS)
1.5.5 Progressive Relapsing Multiple Sclerosis (PRMS)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Stem Cell Therapy for Multiple Sclerosis Market Size
2.2 Stem Cell Therapy for Multiple Sclerosis Growth Trends by Regions
2.2.1 Stem Cell Therapy for Multiple Sclerosis Market Size by Regions (2014-2025)
2.2.2 Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Stem Cell Therapy for Multiple Sclerosis Market Size by Manufacturers
3.1.1 Global Stem Cell Therapy for Multiple Sclerosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
3.2 Stem Cell Therapy for Multiple Sclerosis Key Players Head office and Area Served
3.3 Key Players Stem Cell Therapy for Multiple Sclerosis Product/Solution/Service
3.4 Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-2019)
4.2 Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019)

5 United States
5.1 United States Stem Cell Therapy for Multiple Sclerosis Market Size (2014-2019)
5.2 Stem Cell Therapy for Multiple Sclerosis Key Players in United States
5.3 United States Stem Cell Therapy for Multiple Sclerosis Market Size by Type
5.4 United States Stem Cell Therapy for Multiple Sclerosis Market Size by Application

6 Europe
6.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size (2014-2019)
6.2 Stem Cell Therapy for Multiple Sclerosis Key Players in Europe
6.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type
6.4 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application

7 China
7.1 China Stem Cell Therapy for Multiple Sclerosis Market Size (2014-2019)
7.2 Stem Cell Therapy for Multiple Sclerosis Key Players in China
7.3 China Stem Cell Therapy for Multiple Sclerosis Market Size by Type
7.4 China Stem Cell Therapy for Multiple Sclerosis Market Size by Application

8 Japan
8.1 Japan Stem Cell Therapy for Multiple Sclerosis Market Size (2014-2019)
8.2 Stem Cell Therapy for Multiple Sclerosis Key Players in Japan
8.3 Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Type
8.4 Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size (2014-2019)
9.2 Stem Cell Therapy for Multiple Sclerosis Key Players in Southeast Asia
9.3 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Type
9.4 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Application

10 India
10.1 India Stem Cell Therapy for Multiple Sclerosis Market Size (2014-2019)
10.2 Stem Cell Therapy for Multiple Sclerosis Key Players in India
10.3 India Stem Cell Therapy for Multiple Sclerosis Market Size by Type
10.4 India Stem Cell Therapy for Multiple Sclerosis Market Size by Application

11 Central & South America
11.1 Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size (2014-2019)
11.2 Stem Cell Therapy for Multiple Sclerosis Key Players in Central & South America
11.3 Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size by Type
11.4 Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size by Application

12 International Players Profiles
12.1 American CryoStem
12.1.1 American CryoStem Company Details
12.1.2 Company Description and Business Overview
12.1.3 Stem Cell Therapy for Multiple Sclerosis Introduction
12.1.4 American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)
12.1.5 American CryoStem Recent Development
12.2 Athersys
12.2.1 Athersys Company Details
12.2.2 Company Description and Business Overview
12.2.3 Stem Cell Therapy for Multiple Sclerosis Introduction
12.2.4 Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)
12.2.5 Athersys Recent Development
12.3 Celgene Cellular Therapeutics
12.3.1 Celgene Cellular Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Stem Cell Therapy for Multiple Sclerosis Introduction
12.3.4 Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)
12.3.5 Celgene Cellular Therapeutics Recent Development
12.4 Cell Cure Neurosciences
12.4.1 Cell Cure Neurosciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Stem Cell Therapy for Multiple Sclerosis Introduction
12.4.4 Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)
12.4.5 Cell Cure Neurosciences Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Stem Cell Therapy for Multiple Sclerosis Key Market Segments
Table Key Players Stem Cell Therapy for Multiple Sclerosis Covered
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size Market Share by Type 2014-2025
Figure Intravenous Figures
Table Key Players of Intravenous
Figure Intracerebroventricular Figures
Table Key Players of Intracerebroventricular
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth by Application 2014-2025 (Million US$)
Figure Relapsing-Remitting Multiple Sclerosis (RRMS) Case Studies
Figure Primary Progressive Multiple Sclerosis (PPMS) Case Studies
Figure Secondary Progressive Multiple Sclerosis (SPMS) Case Studies
Figure Progressive Relapsing Multiple Sclerosis (PRMS) Case Studies
Figure Stem Cell Therapy for Multiple Sclerosis Report Years Considered
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size 2014-2025 (Million US$)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions 2014-2025 (Million US$)
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions 2014-2019 (Million US$)
Table Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions 2014-2019
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions 2014-2019
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions 2019
Table Market Top Trends
Table Global Stem Cell Therapy for Multiple Sclerosis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Stem Cell Therapy for Multiple Sclerosis Market Share by Manufacturers (2014-2019)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Share by Manufacturers in 2018
Table Global Stem Cell Therapy for Multiple Sclerosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Stem Cell Therapy for Multiple Sclerosis Product/Solution/Service
Table Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Type (2014-2019)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size Market Share by Type (2014-2019)
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Application (2014-2019)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size Market Share by Application (2014-2019)
Figure Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application in 2018
Figure United States Stem Cell Therapy for Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table United States Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table United States Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2018-2019)
Table United States Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table United States Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2014-2019)
Table United States Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table United States Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2014-2019)
Figure Europe Stem Cell Therapy for Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Europe Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Europe Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2018-2019)
Table Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2014-2019)
Table Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2014-2019)
Figure China Stem Cell Therapy for Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table China Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table China Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2018-2019)
Table China Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-20189) (Million US$)
Table China Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2014-2019)
Table China Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table China Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2014-2019)
Figure Japan Stem Cell Therapy for Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Japan Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Japan Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2018-2019)
Table Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Japan Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2014-2019)
Table Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Japan Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2014-2019)
Figure Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2018-2019)
Table Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2014-2019)
Table Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2014-2019)
Figure India Stem Cell Therapy for Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table India Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table India Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2018-2019)
Table India Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table India Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2014-2019)
Table India Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table India Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2014-2019)
Figure Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2018-2019)
Table Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2014-2019)
Table Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2014-2019)
Table American CryoStem Company Details
Table American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019) (Million US$)
Figure American CryoStem Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)
Table American CryoStem Recent Development
Table Athersys Company Details
Table Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Athersys Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)
Table Athersys Recent Development
Table Celgene Cellular Therapeutics Company Details
Table Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Celgene Cellular Therapeutics Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)
Table Celgene Cellular Therapeutics Recent Development
Table Cell Cure Neurosciences Company Details
Table Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Cell Cure Neurosciences Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2014-2019)
Table Cell Cure Neurosciences Recent Development
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions (Million US$) 2019-2025
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Regions (2019-2025)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Regions in 2025
Figure United States Stem Cell Therapy for Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Stem Cell Therapy for Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure China Stem Cell Therapy for Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Stem Cell Therapy for Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure India Stem Cell Therapy for Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size by Product (2019-2025) (Million US$)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size by Product (2019-2025)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size by Product in 2025
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2019-2025) (Million US$)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2019-2025)
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources